tiprankstipranks
Trending News
More News >
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market

Avidity Biosciences (RNA) Income Statement

Compare
1,101 Followers

Avidity Biosciences Income Statement

Last quarter (Q3 2025), Avidity Biosciences's total revenue was $12.47M, an increase of 434.03% from the same quarter last year. In Q3, Avidity Biosciences's net income was $-174.44M. See Avidity Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.90M$ 9.56M$ 9.22M$ 9.33M$ 6.79M
Gross Profit
$ 10.90M$ 7.46M$ 7.84M$ -91.86M$ -30.82M
Operating Expenses
$ 389.83M$ 243.06M$ 186.75M$ 26.20M$ 13.46M
Depreciation and Amortization
$ 2.78M$ 2.10M$ 1.39M$ 639.00K$ 373.00K
EBITDA
$ -376.16M$ -233.50M$ -177.53M$ -117.41M$ -43.77M
Operating Income
$ -378.94M$ -235.60M$ -178.91M$ -118.05M$ -44.28M
Other Income/Expenses
$ 56.63M$ 23.38M$ 4.92M$ 42.00K$ -78.00K
Pretax Income
$ -322.30M$ -212.22M$ -174.00M$ -118.01M$ -44.35M
Net Income
$ -322.30M$ -212.22M$ -174.00M$ -118.01M$ -44.35M
Per Share Metrics
Basic EPS
$ -2.89$ -2.91$ -3.34$ -2.85$ -2.05
Diluted EPS
$ -2.89$ -2.91$ -3.34$ -2.85$ -2.05
Weighted Average Shares Outstanding
111.58M 73.01M 52.16M 41.43M 21.66M
Weighted Average Shares Outstanding (Diluted)
111.58M 73.01M 52.16M 41.43M 21.66M
Currency in USD

Avidity Biosciences Earnings and Revenue History